SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Teva Neuroscience, Inc. Release: International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease